FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma (FORWARD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03906448 |
|
Recruitment Status :
Terminated
(The study was terminated because the Study Chair/IDE Sponsor and Novocure determined that conducting this trial was not feasible without CMS approval.)
First Posted : April 8, 2019
Last Update Posted : June 17, 2020
|
Sponsor:
University of Florida
Collaborator:
NovoCure Ltd.
Information provided by (Responsible Party):
University of Florida
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | June 8, 2020 |
| Actual Study Completion Date : | June 8, 2020 |